{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:46:53Z","timestamp":1790023613191,"version":"4.0.1"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:p>Sinonasal melanomas encompass melanoma arising in the nasal cavity and paranasal sinuses. Despite recent advances in tumor genomics, correlation between mutational status and protein expression with prognosis and tumor pigmentation has not been carried out in sinonasal melanomas. Ninety-five sinonasal melanomas from 95 patients were included. As per univariate analyses, age was the only variable that significantly correlated with progression-free survival. <jats:italic toggle=\"yes\">SF3B1<\/jats:italic>, <jats:italic toggle=\"yes\">NRAS<\/jats:italic>, <jats:italic toggle=\"yes\">KIT<\/jats:italic>, and <jats:italic toggle=\"yes\">BRAF<\/jats:italic> mutations were documented in 7% (5\/72), 22% (16\/72), 22% (16\/72), and 8% (6\/72) of cases, respectively. Comutation was detected in 6 cases: <jats:italic toggle=\"yes\">NRAS<\/jats:italic> and <jats:italic toggle=\"yes\">KIT<\/jats:italic> in 2 cases; <jats:italic toggle=\"yes\">NRAS<\/jats:italic> and <jats:italic toggle=\"yes\">BRAF<\/jats:italic> in 2 cases; <jats:italic toggle=\"yes\">SF3B1<\/jats:italic>, <jats:italic toggle=\"yes\">KIT<\/jats:italic>, and <jats:italic toggle=\"yes\">BRAF<\/jats:italic> in one case; and <jats:italic toggle=\"yes\">SF3B1<\/jats:italic>, <jats:italic toggle=\"yes\">NRAS<\/jats:italic>, and <jats:italic toggle=\"yes\">KIT<\/jats:italic> in one case. Correlations approaching statistical significance were observed between <jats:italic toggle=\"yes\">BRAF<\/jats:italic> mutation status and poorer overall survival and progression-free survival (log-rank <jats:italic toggle=\"yes\">P<\/jats:italic>-values=0.054 and 0.061). Increased CD117 expression (33%, 29\/88) and decreased nuclear cMYC expression (40%, 39\/84) significantly correlated with cytoplasmic pigmentation. Several <jats:italic toggle=\"yes\">SF3B1<\/jats:italic>, <jats:italic toggle=\"yes\">NRAS<\/jats:italic>, and <jats:italic toggle=\"yes\">KIT<\/jats:italic> mutations not previously documented in sinonasal melanomas were detected in our series, suggesting a potential role for targeted therapies. A similar frequency of <jats:italic toggle=\"yes\">SF3B1<\/jats:italic>, <jats:italic toggle=\"yes\">NRAS<\/jats:italic>, and <jats:italic toggle=\"yes\">KIT<\/jats:italic> mutations was noted in Asian cases, whereas <jats:italic toggle=\"yes\">NRAS<\/jats:italic>, <jats:italic toggle=\"yes\">KIT<\/jats:italic>, and <jats:italic toggle=\"yes\">BRAF<\/jats:italic> mutations were predominant in the United States and European cases; however, the number of included cases was small. The significant association between CD117 and cMYC expression with increased cytoplasmic pigmentation in our series suggests that the pigmented morphologic appearance of sinonasal melanomas could be attributed to the underlying oncogenic mutations and metabolic interaction.<\/jats:p>","DOI":"10.1097\/pas.0000000000001166","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T02:42:35Z","timestamp":1538361755000},"page":"168-177","source":"Crossref","is-referenced-by-count":31,"title":["SF3B1, NRAS, KIT, and BRAF Mutation; CD117 and cMYC Expression; and Tumoral Pigmentation in Sinonasal Melanomas"],"prefix":"10.1097","volume":"43","author":[{"given":"Joanna P.","family":"Wroblewska","sequence":"first","affiliation":[{"name":"Departments of Pathology, Poznan University Medical Sciences and Greater Poland Cancer Center, Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Mull","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Lin","family":"Wu","sequence":"additional","affiliation":[{"name":"National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Wakayama Medical University, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Marszalek","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Poznan University Medical Sciences and Greater Poland Cancer Center, Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai P.","family":"Hoang","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1245\/s10434-011-1685-4","article-title":"Predictors of survival in mucosal melanoma of the head and neck","volume":"18","author":"Jethanamest","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hed.23079","article-title":"Sinonasal mucosal melanoma: molecular profile and therapeutic implications from a series of 32 cases","volume":"35","author":"Turri-Zanoni","year":"2013","journal-title":"Head Neck"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/sj.bjc.6604791","article-title":"Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas","volume":"99","author":"Satzger","year":"2008","journal-title":"Br J Cancer"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/CMR.0b013e32834bf398","article-title":"KIT mutations in Russian patients with mucosal melanoma","volume":"21","author":"Abysheva","year":"2011","journal-title":"Melanoma Res"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00428-007-0524-2","article-title":"C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma","volume":"452","author":"Rivera","year":"2008","journal-title":"Virchows Arch"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/sj.bjc.6605635","article-title":"Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT","volume":"102","author":"Handolias","year":"2010","journal-title":"Br J Cancer"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-08-0575","article-title":"KIT gene mutations and copy number in melanoma subtype","volume":"14","author":"Beadling","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/bjc.2013.373","article-title":"KIT, NRAS, and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases","volume":"109","author":"Zebary","year":"2013","journal-title":"Br J Cancer"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pathol.2016.09.065","article-title":"BRAF, NRAS, KIT, TERT, GNAQ\/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases","volume":"49","author":"Ozturk","year":"2017","journal-title":"Pathology"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/jop.12358","article-title":"Mutation scanning of BRAF, NRAS, KIT, GNAQ\/GNA11 in oral mucosal melanoma: a study of 57 cases","volume":"45","author":"Lyu","year":"2016","journal-title":"J Oral Pathol Med"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"40683","DOI":"10.18632\/oncotarget.16542","article-title":"Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations","volume":"8","author":"Cosgarea","year":"2017","journal-title":"Oncotarget"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/bjc.2017.125","article-title":"Mutational status among patients with sinonasal mucosal melanoma and its impact on survival","volume":"116","author":"Amit","year":"2017","journal-title":"Br J Cancer"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/jdv.14353","article-title":"Mucosal melanoma: clinical, histological, and c-kit gene mutational profile of 86 French cases","volume":"31","author":"Cinotti","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscape of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/CMR.0000000000000345","article-title":"Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma","volume":"27","author":"Hintzsche","year":"2017","journal-title":"Melanoma Res"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00000478-200305000-00004","article-title":"Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system","volume":"27","author":"Thompson","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3892\/or.2012.2190","article-title":"Photodynamic treatment induces cell death by apoptosis or autophagy depending on the melanin content in two B16 melanoma cell lines","volume":"29","author":"Sparsa","year":"2013","journal-title":"Oncol Rep"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"25395","DOI":"10.18632\/oncotarget.15915","article-title":"Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells","volume":"15","author":"Vitiello","year":"2017","journal-title":"Oncotarget"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"17844","DOI":"10.18632\/oncotarget.7528","article-title":"Melanin content in melanoma metastases affects the outcome of radiotherapy","volume":"7","author":"Brozyna","year":"2016","journal-title":"Oncotarget"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/age.12528","article-title":"Association analysis of KIT, MITF, and PAX3 variants with white markings in Spanish horses","volume":"48","author":"Negro","year":"2017","journal-title":"Anim Genet"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/modpathol.2012.75","article-title":"The role of 8q24 copy number gains and c-MYC expression in amelanotic cutaneous melanoma","volume":"25","author":"Pouryazdanparast","year":"2012","journal-title":"Mod Pathol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1371\/journal.pmed.0050120","article-title":"Improving melanoma classification by intergrating genetic and morphologic features","volume":"5","author":"Viros","year":"2008","journal-title":"Plos Med"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11912-015-0485-6","article-title":"Molecular targeted therapy approaches for BRAF wild-type melanoma","volume":"18","author":"Johnpulle","year":"2016","journal-title":"Curr Oncol Rep"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1200\/JCO.2007.14.0707","article-title":"Major response to imatinib mesylate in KIT-mutated melanoma","volume":"26","author":"Hodi","year":"2008","journal-title":"J Clin Oncol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"e1335843","DOI":"10.1080\/2162402X.2017.1335843","article-title":"MEK inhibition and immune responses in advanced melanoma","volume":"6","author":"Dummer","year":"2017","journal-title":"Oncoimmunology"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"10615","DOI":"10.1038\/ncomms10615","article-title":"Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage","volume":"7","author":"Alsafadi","year":"2016","journal-title":"Nat Commun"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1158\/2159-8290.CD-13-0330","article-title":"SF3B1 mutations are associated with alternative splicing in uveal melanoma","volume":"3","author":"Furney","year":"2013","journal-title":"Cancer Discov"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng.2523","article-title":"Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma","volume":"45","author":"Harbour","year":"2013","journal-title":"Nat Genet"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia","volume":"365","author":"Wang","year":"2011","journal-title":"N Engl J Med"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/path.4483","article-title":"SF3B1 mutations constitute a novel therapeutic target in breast cancer","volume":"235","author":"Mcguire","year":"2015","journal-title":"J Pathol"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts","volume":"365","author":"Papaemmaneuil","year":"2011","journal-title":"N Engl J Med"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/CMR.0000000000000071","article-title":"Rare SF3B1 R625 mutations in cutaneous melanoma","volume":"24","author":"Kong","year":"2014","journal-title":"Melanoma Res"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1746-1596-8-87","article-title":"Lack of SF3B1 R625 mutations in cutaneous melanoma","volume":"8","author":"Schilling","year":"2013","journal-title":"Diagn Pathol"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ophtha.2016.01.023","article-title":"Uveal melanomas with SF3B1 mutations: a distinct subclass associated with late-onset metastases","volume":"123","author":"Yavuzyigitoglu","year":"2016","journal-title":"Ophthalmology"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/modpathol.2016.179","article-title":"Identification of recurrent mutational events in anorectal melanoma","volume":"30","author":"Yang","year":"2017","journal-title":"Mod Pathol"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/modpathol.2017.23","article-title":"SF3B1 and BAP1 mutations in blue nevus-like melanoma","volume":"30","author":"Griewank","year":"2017","journal-title":"Mod Pathol"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identified recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia","volume":"44","author":"Quesada","year":"2012","journal-title":"Nat Genet"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/bjd.15836","article-title":"KIT mutations and CD117 overexpression and markers of better progression-free survival in vulvar melanomas","volume":"177","author":"Dias-Santagata","year":"2017","journal-title":"Br J Dermatol"},{"key":"R42-20230922","first-page":"4297","article-title":"Mutation on prognosis of gastrointestinal stromal tumors","volume":"59","author":"Taniguchi","year":"1999","journal-title":"Cancer Res"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"82661","DOI":"10.18632\/oncotarget.19746","article-title":"The clinical significance of c-Kit mutations in metastatic oral mucosal melanoma in China","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"key":"R44-20230922","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s00018-004-4189-6","article-title":"Signal transduction via the stem cell factor receptor\/c-Kit","volume":"61","author":"Ronnstrand","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"R45-20230922","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2007.10.055","article-title":"cis-regulatory changes in KIT ligand expression and parallel evolution of pigmentation in sticklebacks and humans","volume":"131","author":"Miller","year":"2007","journal-title":"Cell"},{"key":"R46-20230922","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/jcb.22053","article-title":"IFI16 and NM23 bind to a common DNA fragment both in the p53 and the cMYC gene promoters","volume":"106","author":"Egistelli","year":"2009","journal-title":"J Cell Biochem"},{"key":"R47-20230922","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0923-1811(92)90006-W","article-title":"Induction of c-fos but not c-myc in S-91 cells by melanization signals","volume":"3","author":"Gordon","year":"1992","journal-title":"J Dermatol Sci"},{"key":"R48-20230922","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3727\/096504002108747908","article-title":"Pigmentation in melanomas: changes manifesting underlying oncogenic and metabolic activities","volume":"13","author":"Halaban","year":"2002","journal-title":"Oncol Res"},{"key":"R49-20230922","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.humpath.2013.02.022","article-title":"Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma","volume":"44","author":"Brozyna","year":"2013","journal-title":"Hum Pathol"},{"key":"R50-20230922","doi-asserted-by":"crossref","first-page":"eaan5692","DOI":"10.1126\/sciimmunol.aan5692","article-title":"A melanin-mediated cancer immunotherapy patch","volume":"2","author":"Ye","year":"2017","journal-title":"Science Immunol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201902000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:43:54Z","timestamp":1695422634000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201902000-00003"}},"subtitle":["An Analysis With Newly Found Molecular Alterations and Some Population-Based Molecular Differences"],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001166","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}